Medication info
Ogutine Tablet 375 mg (Amoxicillin Trihydrate and Clavulanate Potassium)

Ogutine Tablet 375 mg (Amoxicillin Trihydrate and Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›215.52mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
Oval film-coated tablets, white or nearly white
Packaging
100 tablets (10 tablets/PTP × 10)
Approval status
Active

MFDS item code 201309919 · Approved 2013.10.25 · Insurance code 658602740

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
Adults: Administer orally amoxicillin/potassium clavulanate 250 mg/125 mg per dose, 3 times daily every 8 hours. For severe infections and respiratory infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Creatinine clearance 10 ~ 30 mL/min: Administer orally amoxicillin 250 ~ 500 mg per dose every 12 hours. Creatinine clearance 10 mL/min or less: Administer amoxicillin 250 mg per dose every 24 hours, without exceeding the dose. However, for dental infections, administer amoxicillin 250 mg per dose, 3 times daily for 5 days.
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer orally amoxicillin/potassium clavulanate 250 mg/125 mg per dose, 3 times daily every 8 hours. For severe infections and respiratory infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacterial infections. It is primarily used to treat respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscess. It is also helpful in treating urinary tract infections like cystitis, urethritis, and pyelonephritis, as well as sexually transmitted infections like gonorrhea and pelvic inflammatory disease. It is effective for skin infections such as boils, abscesses, soft tissue infections, and wound infections, and is also used in the treatment of osteomyelitis and dental infections. It is used to improve symptoms of multiple bacterial infections.

How to take

Adult dose

Adults: Administer orally amoxicillin/potassium clavulanate 250 mg/125 mg per dose, 3 times daily every 8 hours. For severe infections and respiratory infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Creatinine clearance 10 ~ 30 mL/min: Administer orally amoxicillin 250 ~ 500 mg per dose every 12 hours. Creatinine clearance 10 mL/min or less: Administer amoxicillin 250 mg per dose every 24 hours, without exceeding the dose. However, for dental infections, administer amoxicillin 250 mg per dose, 3 times daily for 5 days.

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer orally amoxicillin/potassium clavulanate 250 mg/125 mg per dose, 3 times daily every 8 hours. For severe infections and respiratory infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Precautions

This medication contains a component that belongs to the beta-lactam class of antibiotics, specifically in the penicillin family. Therefore, patients with hypersensitivity to this medication's components, penicillin, or cephalosporin antibiotics should not use it. Patients with a history of severe allergic reactions such as anaphylaxis, Stevens-Johnson syndrome, or shock should also avoid this medication. Additionally, patients with certain viral infections such as infectious mononucleosis or lymphocytic leukemia may have an increased risk of rash and should be cautious. It is also advisable for patients with a history of liver dysfunction or jaundice to avoid this medication as it may exacerbate symptoms. In patients with impaired liver function or moderate to severe renal impairment, the excretion of this medication may be delayed, requiring careful determination of dosage adjustments and administration intervals. Patients with allergic constitutions or the elderly and those in poor general condition may be at higher risk of side effects and should be closely monitored. This medication may cause gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal pain; in rare cases, it may lead to pseudomembranous colitis or acute pancreatitis. If these symptoms worsen or if blood is present in the stool, the medication should be discontinued immediately and a healthcare provider consulted. Liver dysfunction may lead to hepatitis or jaundice, especially observed more frequently in elderly individuals over 60 years of age or in males. Serious skin reactions such as rashes, urticaria, or Stevens-Johnson syndrome should result in prompt discontinuation of the medication if abnormal symptoms occur. Additionally, blood disorders such as leukopenia, thrombocytopenia, and anemia have been reported rarely, and central nervous system effects such as dizziness or seizures may occur. Renal function abnormalities are also rare, necessitating regular monitoring. This medication may interact with other drugs, particularly anticoagulants, anti-inflammatory drugs, certain antibiotics, and immunosuppressants; caution is advised during concurrent use. For women who are pregnant or breastfeeding, the safety of this medication has not been fully established, so it is essential to consult a healthcare provider before deciding on its use. In children, especially those under 12 years of age or weighing less than 40 kg, there is limited experience with use and should be avoided. In the elderly, the risk of side effects may be higher due to decreased physiological functions, necessitating careful adjustment of the dosage and intervals. In case of overdose, symptoms such as vomiting, diarrhea, rash, and seizures may occur; medication should be discontinued immediately and appropriate emergency care sought. This medication should be stored in a tightly sealed container, protected from moisture, and kept in a cool, dry place below 25 degrees Celsius. It is important to use only for the necessary duration after susceptibility testing to prevent the emergence of resistant strains. If experiencing worsening diarrhea or abdominal pain while taking this medication, consult a healthcare provider immediately. If allergic symptoms or skin rashes occur, discontinue use and follow the healthcare provider's instructions.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vulvar pruritus, burning sensation, increased secretions, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, convulsions, antispasmodic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, mild rash, hyperactivity, drowsiness, renal failure, epileptic convulsions, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a sealed container to prevent moisture and stored in a cool, dry place below 25 degrees Celsius. This storage method helps maintain the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

Oval film-coated tablets, white or nearly white

Package unit

100 tablets (10 tablets/PTP × 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.